There are some prognostic biomarkers for bladder cancer, such as tumor protein 53 (TP53), P21, and tuberous sclerosis 1 (TSC1), but these genes only apply to a fraction of bladder cancer patients [23]. This evidence concerns the gene TSC1 and urinary bladder carcinoma.